Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value ($000): $547,053 (100.0% shares, 0.0% debt)

Holdings (9)

— ABIOMED INC 36.5%

Value ($000) $199,434 Shares 2,150,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 25.0%

Value ($000) $136,659 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— CORIUM INTL INC 16.0%

Value ($000) $87,453 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENTELLUS MED INC 12.6%

Value ($000) $68,714 Shares 3,813,197 Est. Cost $21.90 Unrealized —

— ENDOLOGIX INC 3.9%

Value ($000) $21,220 Shares 1,257,468 Est. Cost $18.00 Unrealized —

AXGN AXOGEN INC 3.7%

Value ($000) $20,028 Shares 4,861,111 Est. Cost $4.01 Unrealized 0.0%

— CATALYST BIOSCIENCES INC 1.0%

Value ($000) $5,658 Shares 1,179,352 Est. Cost $4.80 Unrealized —

ACUR ACURA PHARMACEUTICALS INC 0.8%

Value ($000) $4,598 Shares 1,956,397 Est. Cost $3.40 Unrealized 0.0%

MNOV MEDICINOVA INC 0.6%

Value ($000) $3,289 Shares 1,170,370 Est. Cost $2.95 Unrealized +15.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	2,150,000	$199,434	36.5%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$136,659	25.0%	$31.50	—	COM	761330109
—	CORIUM INTL INC	9,353,304	$87,453	16.0%	$7.77	—	COM	21887L107
—	ENTELLUS MED INC	3,813,197	$68,714	12.6%	$21.90	—	COM	29363K105
—	ENDOLOGIX INC	1,257,468	$21,220	3.9%	$18.00	—	COM	29266S106
AXGN	AXOGEN INC	4,861,111	$20,028	3.7%	$4.01	0.0%	COM	05463X106
—	CATALYST BIOSCIENCES INC	1,179,352	$5,658	1.0%	$4.80	—	COM	14888D109
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$4,598	0.8%	$3.40	0.0%	COM PAR $0.01	00509L802
MNOV	MEDICINOVA INC	1,170,370	$3,289	0.6%	$2.95	+15.8%	COM NEW	58468P206